Aina Aguiló‐Cucurull

ORCID: 0000-0001-5622-778X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunodeficiency and Autoimmune Disorders
  • Chronic Lymphocytic Leukemia Research
  • interferon and immune responses
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • Blood disorders and treatments
  • Cell Adhesion Molecules Research
  • Diabetes and associated disorders
  • Immune Response and Inflammation
  • Parvovirus B19 Infection Studies
  • Respiratory viral infections research
  • Viral Infections and Outbreaks Research
  • NF-κB Signaling Pathways
  • T-cell and B-cell Immunology
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • COVID-19 Clinical Research Studies
  • Gastrointestinal disorders and treatments
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Cystic Fibrosis Research Advances
  • Autoimmune Bullous Skin Diseases
  • RNA regulation and disease
  • Vitamin K Research Studies
  • Viral-associated cancers and disorders

Vall d'Hebron Institut de Recerca
2018-2025

Vall d'Hebron Hospital Universitari
2019-2025

Universitat Autònoma de Barcelona
2019-2020

For the accurate diagnosis of immunodeficiencies is crucial to compare patients' immunology laboratory values with age-sex matched controls, yet there a paucity normal for most populations.To define appropriate reference extended lymphocyte subpopulations and T-cell receptor excision circle (TRECs) levels in healthy pediatric donors between 1 month 18 years age.Extended immunophenotyping were obtained by analysis multiparameter flow cytometry panels following subpopulations: CD4+ CD8+ Naive,...

10.1002/cyto.b.21728 article EN Cytometry Part B Clinical Cytometry 2018-10-17

Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function the immune system. The increasing use next-generation sequencing (NGS) technology has greatly facilitated identification genetic defects in PID patients daily clinical practice. Several NGS approaches are available, from unbiased whole exome (WES) specific gene panels. Here, we report on 3-year experience with (CES) for...

10.3389/fimmu.2019.02325 article EN cc-by Frontiers in Immunology 2019-10-01

Hereditary angioedema (HAE) is a rare genetic disease, characterized by transient and self-limiting episodes of subcutaneous or submucosal swelling that spontaneously resolve within two to five days. The most common form HAE, HAE-C1-INH, caused deleterious mutations in the SERPING1 gene, encoding C1-Inhibitor protein, its diagnosis confirmed decreased C1-INH function. Distinctively from other forms up 15-20% HAE-C1-INH cases are sporadic de novo mutations. Here, we report patient with...

10.3389/fimmu.2025.1550380 article EN cc-by Frontiers in Immunology 2025-02-06

SASH3 is a lymphoid-specific adaptor protein. In recent study, deficiency was described as novel X-linked combined immunodeficiency with immune dysregulation, associated impaired TCR signaling and thymocyte survival in humans. The small number of patients reported to date showed recurrent sinopulmonary, cutaneous mucosal infections, autoimmune cytopenia. Here we describe an adult patient previously diagnosed common variable (CVID) due low IgG IgM levels upper tract infections. Two separate,...

10.3389/fimmu.2022.881206 article EN cc-by Frontiers in Immunology 2022-04-08

X-linked agammaglobulinemia (XLA) is a clinically and genetically well-defined immunodeficiency the most common form of agammaglobulinemia. It characterized by susceptibility to recurrent bacterial infections, profound hypogammaglobulinemia, few or no circulating B cells. XLA caused mutations in BTK gene, which encodes Bruton's tyrosine kinase (BTK). Due its recessive inheritance pattern, virtually only affects males, mother carrier mutation 80% 85% males with this condition. In remaining...

10.3389/fimmu.2020.00046 article EN cc-by Frontiers in Immunology 2020-02-12

Autoimmune lymphoproliferative syndrome (ALPS) is a rare primary immune disorder characterized by impaired apoptotic homeostasis. The clinical characteristics include lymphoproliferation, autoimmunity (mainly cytopenia), and an increased risk of lymphoma. A distinctive biological feature accumulation (>2.5%) abnormal cell subset composed TCRαβ + CD4 - CD8 T cells (DNTs). most common genetic causes ALPS are monoallelic pathogenic variants in the FAS gene followed somatic variants,...

10.3389/fimmu.2022.1014984 article EN cc-by Frontiers in Immunology 2022-11-18
Coming Soon ...